At least two classes of genes have been identified, which are important in the pathogenesis of cancer. The first class was originally discovered by the work on acutely transforming RNA tumor viruses and consists of the oncogenes. Activation of these genes by mutation, chromosome translocation or by other means, provides an essential step in the multistage process of malignant transformation. The second class which includes the socalled anti-oncogenes, has been identified in studies of hereditary cancers, in particular Wilms' tumor and retinoblastoma. Whereas oncogenes behave dominantly (one activated copy is sufficient for producing cancer), the antioncogenes show a recessive mode of cancer initiation both alleles have to be inactivated. An example of the first class is the abelson oncogene (c-abl) which seems to play an essential role in chronic myeloid leukemia (CML). CML is Iharacterized by the presence of the Philadelphia (Ph ) chromosome in thelleukemic cells of 96% of all CML patients. The Ph chromosome (22q-) is the result of a reciprocal translocation between chromosome 22 and The availability of human DNA sequences in recomchromosome 9, t(9q34,22qll). previously we described binants has transformed human genetics. There are the localization of the human c-abl oncogene on now approximately five hundred coding gene sequences, chromo~ome 9 and demonstrated its translocation to and innumerable localised anonymous probes, cloned the Ph chromosome in CML patients (1). The cloning and available pure and in unlimited amount. These and analysis of breakpoint fragments revealed that can be used by clinical molecular pathologists to the breakpoints on chromosome 22 all cluster in a study genes in a person-specific way, since any cloned very limited area, the breakpoint cluster region, gene sequence is unique to the person from whom it is bcr (2). Breakpoints on chromosome 9, however, are isolated. Therefore, all of the heritable parameters scattered over a large area. The detection of a of individuality, whether representing pathological chimeric mRNA (5'bcr and 3'abl sequences) in the or normal variation, can be studied by comparing gene leukemic cells of CML patients (3,4) and the cloning sequences.
of chimeric cDNAs from a CML derived cell line K562 Many of the cloned human coding genes which have (5,6) strongly indicate that bcr and c-abl coding been isolated and characterised to date are also in-sequences are linked by RNA splicing, independent volved in single gene pathology. These include the from the distance between the two genes on the Ph 1 sequences known to be mutated so as to cause known chromosome. These findings suggest an important role and characterised Mendelian disorders, such as thalas· for the altered c-abl product in the generation and/ saemia, PKU or haemophilia. In such cases, the under-or maintenance of CML. lying molecular nature of the defect can be deterStrong evidence for the existence of the second mined, and the probe can be used for population-based class of genes the socalled anti-oncogenes comes carrier testing and for uneqUivocal prenatal diagfrom studies of Wilms' tumor and retinoblastoma. nosis. Other common single gene defects of unknown Both tumors seem to be the result of loss or biochemistry, such as cystic fibrosis and Duchenne inactivation of the two alleles of a wild type gene muscular dystrophy, have been linked either to known located on Ilp13 in the case of Wilms' tumor (7) DNA coding sequences, or to anonymous DNA probes and 13q14 in retinoblastoma (8). In the here1itary which are chromosomally localised. In these cases, form of these tumors the first inactivation event is carrier detection and prenatal (or presymptomatic) present in the germ line as a mutation or chromosome diagnosis is only available to informative families deletion, whereas in the non-hereditary cases with living affected members.
(mostly unilaterally affected) the first inactivation A complete map of the human genome will soon be event occurs in the somatic cell. 
